| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.085 | 0.006 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |